Warning Letter Roundup: FDA Warns Six Facilities for GMP, Other Failures

Drug GMP Report
The FDA issued recent warning letters to manufacturing facilities in India, South Korea, China and the U.S., for a wide range of deficiencies, including inadequate testing.

To View This Article:


Subscribe To Drug GMP Report

Buy This Article Now

Add this article to your cart for $40.00